BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 33854496)

  • 1. Mechanisms of Peritoneal Fibrosis: Focus on Immune Cells-Peritoneal Stroma Interactions.
    Terri M; Trionfetti F; Montaldo C; Cordani M; Tripodi M; Lopez-Cabrera M; Strippoli R
    Front Immunol; 2021; 12():607204. PubMed ID: 33854496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis.
    Strippoli R; Moreno-Vicente R; Battistelli C; Cicchini C; Noce V; Amicone L; Marchetti A; Del Pozo MA; Tripodi M
    Stem Cells Int; 2016; 2016():3543678. PubMed ID: 26941801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleiotrophin triggers inflammation and increased peritoneal permeability leading to peritoneal fibrosis.
    Yokoi H; Kasahara M; Mori K; Ogawa Y; Kuwabara T; Imamaki H; Kawanishi T; Koga K; Ishii A; Kato Y; Mori KP; Toda N; Ohno S; Muramatsu H; Muramatsu T; Sugawara A; Mukoyama M; Nakao K
    Kidney Int; 2012 Jan; 81(2):160-9. PubMed ID: 21881556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative activation of macrophages in human peritoneum: implications for peritoneal fibrosis.
    Bellón T; Martínez V; Lucendo B; del Peso G; Castro MJ; Aroeira LS; Rodríguez-Sanz A; Ossorio M; Sánchez-Villanueva R; Selgas R; Bajo MA
    Nephrol Dial Transplant; 2011 Sep; 26(9):2995-3005. PubMed ID: 21324976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dipeptide alanyl-glutamine ameliorates peritoneal fibrosis and attenuates IL-17 dependent pathways during peritoneal dialysis.
    Ferrantelli E; Liappas G; Vila Cuenca M; Keuning ED; Foster TL; Vervloet MG; Lopéz-Cabrera M; Beelen RH
    Kidney Int; 2016 Mar; 89(3):625-35. PubMed ID: 26880457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPAR-γ agonist rosiglitazone protects peritoneal membrane from dialysis fluid-induced damage.
    Sandoval P; Loureiro J; González-Mateo G; Pérez-Lozano ML; Maldonado-Rodríguez A; Sánchez-Tomero JA; Mendoza L; Santamaría B; Ortiz A; Ruíz-Ortega M; Selgas R; Martín P; Sánchez-Madrid F; Aguilera A; López-Cabrera M
    Lab Invest; 2010 Oct; 90(10):1517-32. PubMed ID: 20531289
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo analysis of dialysis effluent-derived mesothelial cells as an approach to unveiling the mechanism of peritoneal membrane failure.
    López-Cabrera M; Aguilera A; Aroeira LS; Ramírez-Huesca M; Pérez-Lozano ML; Jiménez-Heffernan JA; Bajo MA; del Peso G; Sánchez-Tomero JA; Selgas R
    Perit Dial Int; 2006; 26(1):26-34. PubMed ID: 16538870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediators of inflammation and fibrosis.
    Lai KN; Tang SC; Leung JC
    Perit Dial Int; 2007 Jun; 27 Suppl 2():S65-71. PubMed ID: 17556333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sterile inflammation of peritoneal membrane caused by peritoneal dialysis: focus on the communication between immune cells and peritoneal stroma.
    Su H; Zou R; Su J; Chen X; Yang H; An N; Yang C; Tang J; Liu H; Yao C
    Front Immunol; 2024; 15():1387292. PubMed ID: 38779674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
    Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
    Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial to mesenchymal transition and peritoneal membrane failure in peritoneal dialysis patients: pathologic significance and potential therapeutic interventions.
    Aroeira LS; Aguilera A; Sánchez-Tomero JA; Bajo MA; del Peso G; Jiménez-Heffernan JA; Selgas R; López-Cabrera M
    J Am Soc Nephrol; 2007 Jul; 18(7):2004-13. PubMed ID: 17568021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1-VEGF-A pathway induces neoangiogenesis with peritoneal fibrosis in patients undergoing peritoneal dialysis.
    Kariya T; Nishimura H; Mizuno M; Suzuki Y; Matsukawa Y; Sakata F; Maruyama S; Takei Y; Ito Y
    Am J Physiol Renal Physiol; 2018 Feb; 314(2):F167-F180. PubMed ID: 28978530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Therapeutic Potential of Human Umbilical Mesenchymal Stem Cells From Wharton's Jelly in the Treatment of Rat Peritoneal Dialysis-Induced Fibrosis.
    Fan YP; Hsia CC; Tseng KW; Liao CK; Fu TW; Ko TL; Chiu MM; Shih YH; Huang PY; Chiang YC; Yang CC; Fu YS
    Stem Cells Transl Med; 2016 Feb; 5(2):235-47. PubMed ID: 26718649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WNT signaling is required for peritoneal membrane angiogenesis.
    Padwal M; Cheng G; Liu L; Boivin F; Gangji AS; Brimble KS; Bridgewater D; Margetts PJ
    Am J Physiol Renal Physiol; 2018 Jun; 314(6):F1036-F1045. PubMed ID: 29363326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of advanced glycation end products and beta 2-microglobulin in fibrotic thickening of the peritoneum in long-term peritoneal dialysis patients.
    Nakamoto H; Hamada C; Shimaoka T; Sekiguchi Y; Io H; Kaneko K; Horikoshi S; Tomino Y
    J Artif Organs; 2014 Mar; 17(1):60-8. PubMed ID: 24337623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients.
    Zhou Q; Bajo MA; Del Peso G; Yu X; Selgas R
    Kidney Int; 2016 Sep; 90(3):515-24. PubMed ID: 27282936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors increasing severity of peritonitis in long-term peritoneal dialysis patients.
    Park MS
    Adv Ren Replace Ther; 1998 Jul; 5(3):185-93. PubMed ID: 9686629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory macrophages switch to CCL17-expressing phenotype and promote peritoneal fibrosis.
    Chen YT; Hsu H; Lin CC; Pan SY; Liu SY; Wu CF; Tsai PZ; Liao CT; Cheng HT; Chiang WC; Chen YM; Chu TS; Lin SL
    J Pathol; 2020 Jan; 250(1):55-66. PubMed ID: 31579932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pentraxin 3 as a new biomarker of peritoneal injury in peritoneal dialysis patients.
    Kanda R; Hamada C; Kaneko K; Nakano T; Wakabayashi K; Io H; Horikoshi S; Tomino Y
    J Artif Organs; 2013 Mar; 16(1):66-73. PubMed ID: 23010754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New developments in peritoneal fibroblast biology: implications for inflammation and fibrosis in peritoneal dialysis.
    Witowski J; Kawka E; Rudolf A; Jörres A
    Biomed Res Int; 2015; 2015():134708. PubMed ID: 26495280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.